Miragen Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.0M | 139k | 21.58 |
| 2025-06-30 | $2.7M | 190k | 13.98 |
| 2025-03-31 | $1.8M | 131k | 13.48 |
| 2024-12-31 | $2.2M | 116k | 19.17 |
| 2024-09-30 | $2.0M | 90k | 22.75 |
| 2024-06-30 | $902k | 69k | 13.01 |
| 2024-03-31 | $496k | 28k | 17.51 |
| 2023-12-31 | $330k | 15k | 21.78 |
| 2023-09-30 | $233k | 15k | 15.34 |
| 2023-06-30 | $601k | 24k | 25.44 |
| 2023-03-31 | $601k | 24k | 25.44 |
| 2022-12-31 | $569k | 20k | 29.21 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas